View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
SHL|14 August 2019

Rotaject® Technology

A constant-force technology that allows the delivery of highly viscous formulations of up to several hundred centipoise.

A constant-force technology that allows the delivery of highly viscous formulations of up to several hundred centipoise.

Rotaject® is constant-force technology that allows the delivery of highly viscous formulations of up to several hundred centipoise. To meet the request for a wider variety of fill volumes for next-generation biological formulations, the technology can be customized into a disposable auto-injector using either a 1mL or a larger 2.25mL syringe.

  • Simple 2-step operation
  • Needle cover activation
  • Compatible with automatic or manual needle insertion
  • Supports audible, visual & tactile feedback mechanisms during the injection
  • Proven in clinical & commercial use
  • Human Factors engineering for optimum patient comfort
  • Supports passive locking needle cover to reduce risk of needle-stick injuries

SHL has extensive experience in the parenteral arena. In this article, SHL details its latest offerings in the world of biologics, as well as its...
Despite being founded in an age when medical devices were more about getting the job done than providing optimum patient experience, SHL Group has from...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU